|
MLL5 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.238910E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.381100E-03 |
| Normal-vs-Stage2 |
7.138100E-03 |
| Normal-vs-Stage3 |
5.411800E-04 |
| Normal-vs-Stage4 |
8.750200E-04 |
| Stage1-vs-Stage2 |
4.419000E-01 |
| Stage1-vs-Stage3 |
1.532550E-01 |
| Stage1-vs-Stage4 |
2.007200E-01 |
| Stage2-vs-Stage3 |
8.000000E-01 |
| Stage2-vs-Stage4 |
8.223000E-01 |
| Stage3-vs-Stage4 |
9.862600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.764050E-03 |
| Normal-vs-AfricanAmerican |
2.316000E-01 |
| Normal-vs-Asian |
4.699600E-02 |
| Caucasian-vs-AfricanAmerican |
4.036400E-01 |
| Caucasian-vs-Asian |
5.455000E-01 |
| AfricanAmerican-vs-Asian |
7.405600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.961590E-03 |
| Normal-vs-Female |
1.984230E-03 |
| Male-vs-Female |
9.061200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.357500E-02 |
| Normal-vs-Age(41-60Yrs) |
4.283800E-03 |
| Normal-vs-Age(61-80Yrs) |
2.22289999999292E-05 |
| Normal-vs-Age(81-100Yrs) |
1.076380E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.995000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.872090E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.831800E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.030780E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.315800E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.718400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.814100E-02 |
| Classical-VS-Follicular |
1.061850E-03 |
| Classical-VS-Other |
7.983200E-01 |
| Classical-VS-Normal |
3.252400E-02 |
| Tall-VS-Follicular |
9.868000E-01 |
| Tall-VS-Other |
3.635800E-01 |
| Tall-VS-Normal |
5.585000E-04 |
| Follicular-VS-Other |
4.406200E-01 |
| Follicular-VS-Normal |
9.8382000000008E-05 |
| Other-VS-Normal |
2.732400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.417600E-04 |
| Normal-vs-N1 |
1.064060E-02 |
| N0-vs-N1 |
5.861200E-01 |
|
|
